Jon not coming to or not communicating on FFS requirements to start phase III is probably the catalyst. Share price has deteriorated since then.
Hard to pick good entry points in such companies.
Patience and trust in the company is definitely needed![]()
- Forums
- ASX - By Stock
- Ann: Trofinetide marketing application submitted in Europe
NEU
neuren pharmaceuticals limited
Add to My Watchlist
5.18%
!
$14.00

Jon not coming to or not communicating on FFS requirements to...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.00 |
Change
0.690(5.18%) |
Mkt cap ! $1.730B |
Open | High | Low | Value | Volume |
$13.50 | $14.09 | $12.96 | $4.848M | 354.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 174 | $13.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.01 | 797 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 26 | 14.000 |
5 | 291 | 13.990 |
8 | 1205 | 13.980 |
6 | 1275 | 13.970 |
4 | 715 | 13.960 |
Price($) | Vol. | No. |
---|---|---|
14.030 | 434 | 3 |
14.040 | 597 | 4 |
14.050 | 1442 | 6 |
14.060 | 1554 | 5 |
14.070 | 1537 | 7 |
Last trade - 12.37pm 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online